Streetbeat News

Earnings

CHEK

Check-Cap Ltd. (NASDAQ:CHEK) reported a Q3 EPS loss of $(0.44), which is significantly below the $(0.29) analyst consensus estimate, marking a 51.72% miss and a substantial decrease from the $(0.04) per share loss reported in the same quarter last year.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:07 pm

ICAD

iCAD, Inc. (NASDAQ:ICAD) presented new research at the RSNA annual meeting, showcasing its ProFound Breast Health Suite's ability to predict breast cancer risk and detect heart disease. The AI-powered suite can assess calcium deposits in breast arteries, indicating cardiovascular disease. Studies confirmed the suite's effectiveness in cancer detection and standardizing breast arterial calcifications (BAC) reporting. Dr. Emily Conant and other researchers highlighted the potential of iCAD's 4th generation Breast AI in improving patient outcomes. The company's solutions are at various stages of regulatory approval, with some pending FDA clearance.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:07 pm

AVXL

Anavex Life Sciences (NASDAQ:AVXL) reported a smaller-than-expected loss of $(0.12) per share for Q4, beating the consensus estimate of $(0.15) by 20%. This represents a 33.33% improvement from the $(0.18) per share loss reported in the same quarter last year.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:06 pm

CRNC

Cerence Inc. (CRNC) reported Q4 adjusted earnings per share (EPS) of $0.09, missing the consensus estimate of $0.15 by 40%. However, the company's quarterly sales of $80.76M exceeded expectations of $73.38M by 10.06%, marking a 38.90% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 12:58 pm

GSK

GSK plc announced positive Phase 3 trial results for belantamab mafodotin, showing significant improvement in progression-free survival for multiple myeloma compared to the standard of care. Despite previous setbacks with FDA and EMA regulatory issues, the encouraging data could signal a potential comeback for the drug, marketed as Blenrep. GSK shares saw minimal change in premarket trading.

Portfolio Pulse from Vandana Singh

November 27, 2023 | 12:57 pm

APG

APi Group has updated its strategic initiatives for the Chubb business, increasing its run-rate value capture target by 25% from $100 million to $125 million, as announced during the company's Investor Day meeting one year ago.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 12:27 pm

CRNC

Cerence (NASDAQ:CRNC) reported Q4 earnings with an EPS of $0.09, missing the estimate of $0.15 by 40%. Despite the miss, revenue increased by $22.62 million compared to the same period last year. In the previous quarter, Cerence beat the EPS estimate but the share price fell by 1.87% the following day.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 12:05 pm

CCI

DIS

QQQ

SPY

ZS

U.S. stocks are expected to pause after recent gains, with a data-heavy week ahead potentially influencing market direction. Last week, major indices like the Nasdaq Composite, S&P 500, and Dow Industrials posted their fourth consecutive week of gains. Analysts anticipate a year-end rally based on historical patterns. Futures indicate a modestly lower opening, with SPY and QQQ slightly down in premarket trading. Walt Disney Co. (DIS) shares fell premarket after a weak box office performance, while Crown Castle Inc. (CCI) rose after Elliott Investment Management reportedly built a significant stake. Zscaler, Inc. (ZS) is set to release quarterly results. Crude oil prices dropped ahead of the OPEC+ meeting, and the 10-year Treasury note yield decreased slightly.

Portfolio Pulse from Shanthi Rexaline

November 27, 2023 | 12:04 pm

CRNC

Cerence Inc. (CRNC) reported a significant decline in its Q4 financial results, with adjusted earnings per share (EPS) dropping to $(0.14) from $0.09 year-over-year (YoY), and sales falling to $58.14 million from $80.76 million YoY, representing a 255.56% decrease in EPS and a 28.01% decrease in sales.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 12:03 pm

EM

Smart Share Glb (NASDAQ:EM) reported Q3 earnings with an EPS of $0.03, missing estimates by 70% against the expected $0.1. Revenue also declined by $30.48 million compared to the same period last year. The company's stock price dropped by 0.54% the day after missing Q2 EPS estimates.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 11:40 am